Breast Conservation after Neoadjuvant Chemotherapy for Stage II Carcinoma of the Breast
β Scribed by Gordon F. Schwartz; Andrew J. Meltzer; Elizabeth A. Lucarelli; Joshua P. Cantor; Paul G. Curcillo II
- Book ID
- 113676514
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 147 KB
- Volume
- 201
- Category
- Article
- ISSN
- 1072-7515
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Randomized trials comparing neoadjuvant versus adjuvant chemotherapy show that primary chemotherapy allows more frequent breastβpreserving surgery even though no survival advantage has been demonstrated. The aim of the current study was to determine the predicting factors
up for surviving patients was 95 months (range, 68-157 months). Pathology slides were available for review in 19 cases. Cosmetic results and complications after 1 Joint Center for Radiation Therapy and Depart-BCT were scored. Outcome was compared with that of 1314 patients with unilateral ment of Ra